A.M. Couroucé

1.8k total citations
62 papers, 1.1k citations indexed

About

A.M. Couroucé is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, A.M. Couroucé has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 36 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in A.M. Couroucé's work include Hepatitis B Virus Studies (35 papers), Hepatitis C virus research (34 papers) and HIV Research and Treatment (12 papers). A.M. Couroucé is often cited by papers focused on Hepatitis B Virus Studies (35 papers), Hepatitis C virus research (34 papers) and HIV Research and Treatment (12 papers). A.M. Couroucé collaborates with scholars based in France, United States and Australia. A.M. Couroucé's co-authors include Heléne Norder, Sven Löfdahl, Lars O. Magnius, Berit Hammas, Josiane Pillonel, Fernando Simón, Didier Ingrand, Ibtissam Loussert-Ajaka, A Girault and Sentob Saragosti and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

A.M. Couroucé

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Couroucé France 15 814 727 286 231 88 62 1.1k
Richard Smith United States 8 660 0.8× 395 0.5× 822 2.9× 853 3.7× 173 2.0× 10 1.5k
Sigrid Nick Germany 14 445 0.5× 297 0.4× 151 0.5× 236 1.0× 137 1.6× 33 645
L. H. Barbosa United States 12 873 1.1× 816 1.1× 201 0.7× 47 0.2× 48 0.5× 16 1.1k
Martine Mariotti France 20 473 0.6× 380 0.5× 400 1.4× 285 1.2× 156 1.8× 39 968
Lorraine Peddada United States 7 518 0.6× 260 0.4× 769 2.7× 855 3.7× 175 2.0× 7 1.3k
AM Couroucé France 11 452 0.6× 400 0.6× 115 0.4× 65 0.3× 71 0.8× 30 589
James Gallarda United States 13 249 0.3× 236 0.3× 182 0.6× 94 0.4× 65 0.7× 17 655
J. W. Mosley United States 15 295 0.4× 179 0.2× 385 1.3× 282 1.2× 144 1.6× 35 825
Yuji Hoshi Japan 14 552 0.7× 534 0.7× 248 0.9× 33 0.1× 54 0.6× 24 880
Marie‐Christine Dazza France 19 421 0.5× 208 0.3× 355 1.2× 383 1.7× 231 2.6× 41 979

Countries citing papers authored by A.M. Couroucé

Since Specialization
Citations

This map shows the geographic impact of A.M. Couroucé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Couroucé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Couroucé more than expected).

Fields of papers citing papers by A.M. Couroucé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Couroucé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Couroucé. The network helps show where A.M. Couroucé may publish in the future.

Co-authorship network of co-authors of A.M. Couroucé

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Couroucé. A scholar is included among the top collaborators of A.M. Couroucé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Couroucé. A.M. Couroucé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laperche, Syria, et al.. (2001). Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type‐specific epitopes of HBsAg. Journal of Viral Hepatitis. 8(6). 447–453. 11 indexed citations
2.
Laperche, Syria, et al.. (2000). Les tests de dépistage combiné de l'antigène p24 et des anticorps anti-VIH dans l'infection précoce à VIH-I. Transfusion Clinique et Biologique. 7. 18s–24s. 21 indexed citations
3.
Barin, Françis, Syria Laperche, & A.M. Couroucé. (2000). Diversité génétique des virus Conséquences pour le dépistage et la prévention. Transfusion Clinique et Biologique. 7(5). 472–478. 2 indexed citations
4.
Couroucé, A.M., Josiane Pillonel, J.M. Lemaire, & C. Saura. (1998). HTLV Testing in Blood Transfusion. Vox Sanguinis. 74(S2). 165–169. 13 indexed citations
7.
Laperche, Syria & A.M. Couroucé. (1997). Évolution du diagnostic biologique des hépatites C. Transfusion Clinique et Biologique. 4(3). 291–298. 6 indexed citations
8.
Couroucé, A.M.. (1995). Séropositivité VIH dans les dons de sang : prévalence, risque résiduel et épidémiologie. Transfusion Clinique et Biologique. 2(5). 357–363. 4 indexed citations
9.
Echevarrı́a, Juan E., Antônio Tenório, A.M. Couroucé, P. León, & José Manuel Echevarría. (1994). Polymerase chain reaction can resolve some undefined cases of Hepatitis B virus antigenic subtyping. Journal of Medical Virology. 42(3). 217–223. 7 indexed citations
10.
Couroucé, A.M., Nadine Le Marrec, A Girault, S. Ducamp, & Nicole Simon. (1994). Anti‐hepatitis C virus (anti‐HCV) seroconversion in patients undergoing hemodialysis: comparison of second‐ and third‐generation anti‐HCV assays. Transfusion. 34(9). 790–795. 79 indexed citations
11.
Jungers, P, Philippe Chauveau, A.M. Couroucé, et al.. (1994). Immunogenicity of the Recombinant GenHevac B Pasteur Vaccine against Hepatitis B in Chronic Uremic Patients. The Journal of Infectious Diseases. 169(2). 399–402. 26 indexed citations
12.
Bouchardeau, Françoise, Philippe Chauveau, Nadine Le Marrec, et al.. (1993). Corrélation entre l'ARN du virus de l'hépatite C (VHC) et les anticorps anti-VHC dans une population d'hémodialysés. PubMed. 36(5). 451–464. 3 indexed citations
13.
Couroucé, A.M., V. Massari, M. Maniez, et al.. (1993). Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. European Journal of Clinical Microbiology & Infectious Diseases. 12(9). 668–672. 8 indexed citations
14.
Bouchardeau, Françoise, Philippe Chauveau, Nadine Le Marrec, et al.. (1993). Detection of hepatitis C virus by polym erase chain reaction in haemodialysed patients in relationship to anti-HCV status. Research in Virology. 144(3). 233–242. 10 indexed citations
15.
Maisonneuve, Patrick, A.M. Couroucé, C Guérois, et al.. (1992). Anti-VHC et receveurs : situation chez les hémophiles en 1991. PubMed. 35(3). 193–198. 4 indexed citations
16.
Sazama, Kathleen, I. K. Kuramoto, P. V. Holland, et al.. (1992). Detection of antibodies to human immunodeficiency virus type 2 (HIV‐2) in blood donor sera using United States assay methods for anti‐HIV type 1. Transfusion. 32(5). 398–401. 2 indexed citations
17.
Morinet, F., A.M. Couroucé, Francis Galibert, & Y Pérol. (1991). The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test. Journal of Virological Methods. 32(1). 21–30. 13 indexed citations
18.
Salmon, D., P. Lambin, A.M. Couroucé, et al.. (1990). Essai de prédiction de l'évolution vers le SIDA d'une cohorte de 77 séropositifs : intérêt de l'antigénémie p24 et du taux des IgA sériques. 33(1). 21–29.
19.
Couroucé, A.M., et al.. (1990). Anti‐Hepatitis C Antibodies in Prospectively Followed‐Up Transfused Patients. Vox Sanguinis. 58(3). 226–227. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026